Matthias Schönermark

from Wikipedia, the free encyclopedia

Matthias P. Schönermark (born February 19, 1964 in Essen ) is a German ENT doctor , university professor , management consultant and coach .

Life

As the son of a head doctor in Öhringen , Schönermark joined the army (Bundeswehr) after graduating from high school . Dismissed as a lieutenant , he went on to study general studies at the Ludwig Maximilians University in Munich in 1984/85 . He switched to the Georg-August University in Göttingen to study medicine . In 1984 he became a member of the Corps Isaria and 1985 of the Corps Hannovera Göttingen . He did the Physikum 1986 in Munich. He completed the clinical part of his studies at the Ruprecht-Karls-Universität Heidelberg , the University of London and the University of Cape Town . He received his doctorate in 1991 for Dr. med. and has worked as a postgraduate at Columbia University and Dartmouth Medical School in Hanover, NH, among others . He became a specialist in ear, nose and throat medicine in 1997 at the Hannover Medical School (MHH) .

After completing his habilitation in 1998 , he joined the Boston Consulting Group . In 2001/02 he was CEO at MWG-Biotech . After an interlude as Associate Director at AT Kearney , he founded Schönermark Kielhorn Collegen (SKC) Beratungsgesellschaft mbH in 2004 , where he works as a managing partner. Schönermark is a member of the supervisory boards of DOREA GmbH and HeartGenetics, Genetics & Biotechnology, SA.

Since 2000 professor for medical management at the MHH, he founded the Hannover School of Health Management (HSHM). He teaches strategic management at US and European universities . In 2015 he qualified as a systemic therapist.

Schönermark has published over 300 publications in scientific journals and the general press. The core topics are molecular oncology , cancer research , strategy , health management , HTA (Health Technology Assessment) , leadership and digital health.

Schönermark is married and has five children. As a volunteer, he is a member of the Board of Trustees for the Center for Biomedical Technology and Innovation, BiomeTI Hanover and the steering committee of the future workshop GKV.

Publications (selection)

  • Human glomerular mesangial cells. Cultivation, characterization and interactions with inflammation mediators , 1991 (PhD thesis).
  • The influence of retinoid acid on the molecular mechanisms of metalloproteinase-mediated matrix degradation and tumor invasion , 1997 (habilitation thesis).

Web links

Individual evidence

  1. SKC Consulting Company - Management. In: skc-beratung.de. SKC Consulting Company, accessed April 17, 2018 .
  2. ^ Xing - Coaches & Trainers. In: Xing. Xing, accessed on April 17, 2018 .
  3. Kösener Corpslisten 1996, 82/1560; 59/1315
  4. Manager Magazin
  5. SKC
  6. DOREA family - companies. In: doreafamilie.de. DOREA GmbH, accessed on April 17, 2018 .
  7. Heart Genetics - Advisory Board. In: heartgenetics.com. HeartGenetics, Genetics & Biotechnology, SA, accessed April 17, 2018 .
  8. Medical management MHH
  9. HSHM
  10. BiomeTI
  11. Future workshop GKV (PDF; 66 kB)